Snowden Capital Advisors LLC Eli Lilly & CO Transaction History

Snowden Capital Advisors LLC

  • $3.31 Billion
  • Q2 2024

A detailed history of Snowden Capital Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 30,619 shares of LLY stock, worth $27.8 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
30,619
Previous 31,011 1.26%
Holding current value
$27.8 Million
Previous $24.1 Million 14.91%
% of portfolio
0.84%
Previous 0.76%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$724.87 - $909.04 $284,149 - $356,343
-392 Reduced 1.26%
30,619 $27.7 Million
Q1 2024

May 15, 2024
BUY
$592.2 - $792.28 $4.54 Million - $6.07 Million
7,658 Added 32.79%
31,011 $24.1 Million
Q4 2023

Feb 14, 2024
BUY
$525.19 - $619.13 $2.52 Million - $2.97 Million
4,792 Added 25.82%
23,353 $13.6 Million
Q3 2023

Nov 14, 2023
SELL
$434.7 - $599.3 $6.62 Million - $9.13 Million
-15,237 Reduced 45.08%
18,561 $9.97 Million
Q2 2023

Aug 14, 2023
BUY
$350.74 - $468.98 $2.5 Million - $3.35 Million
7,139 Added 26.78%
33,798 $15.9 Million
Q1 2023

May 15, 2023
BUY
$310.63 - $364.82 $123,630 - $145,198
398 Added 1.52%
26,659 $9.16 Million
Q4 2022

Feb 13, 2023
BUY
$321.55 - $374.67 $181,354 - $211,313
564 Added 2.19%
26,261 $9.61 Million
Q3 2022

Nov 09, 2022
BUY
$296.48 - $337.87 $695,838 - $792,980
2,347 Added 10.05%
25,697 $8.31 Million
Q2 2022

Aug 12, 2022
BUY
$278.73 - $327.27 $1.38 Million - $1.62 Million
4,938 Added 26.82%
23,350 $7.57 Million
Q1 2022

May 16, 2022
BUY
$234.69 - $291.66 $3.62 Million - $4.49 Million
15,404 Added 512.1%
18,412 $5.27 Million
Q4 2021

Feb 14, 2022
BUY
$224.85 - $279.04 $676,348 - $839,352
3,008 New
3,008 $831,000
Q3 2021

Feb 05, 2024
SELL
$221.6 - $272.71 $2.16 Million - $2.66 Million
-9,753 Reduced 52.55%
8,808 $2.04 Billion
Q2 2021

Jan 08, 2024
BUY
$180.55 - $233.54 $41,707 - $53,947
231 Added 3.03%
7,844 $1.8 Billion
Q1 2021

Jan 08, 2024
BUY
$164.32 - $212.72 $230,540 - $298,446
1,403 Added 22.59%
7,613 $1.42 Billion
Q4 2020

Jan 08, 2024
BUY
$130.46 - $172.63 $149,898 - $198,351
1,149 Added 22.7%
6,210 $1.05 Billion
Q3 2020

Jan 08, 2024
SELL
$146.22 - $169.13 $7,164 - $8,287
-49 Reduced 0.96%
5,061 $749 Million
Q2 2020

Jan 08, 2024
BUY
$136.42 - $164.18 $101,496 - $122,149
744 Added 17.04%
5,110 $839 Million
Q1 2020

Jan 08, 2024
BUY
$119.05 - $147.35 $293,101 - $362,775
2,462 Added 129.31%
4,366 $606 Million
Q4 2019

Jan 30, 2024
BUY
$106.92 - $132.43 $7,056 - $8,740
66 Added 3.59%
1,904 $250 Million
Q4 2019

Jan 08, 2024
BUY
$106.92 - $132.43 $7,056 - $8,740
66 Added 3.59%
1,904 $250 Million
Q3 2019

Jan 30, 2024
SELL
$106.79 - $116.16 $13,348 - $14,520
-125 Reduced 6.37%
1,838 $206 Million
Q3 2019

Jan 08, 2024
SELL
$106.79 - $116.16 $91,625 - $99,665
-858 Reduced 31.82%
1,838 $206 Million
Q2 2019

Jan 30, 2024
SELL
$110.79 - $129.32 $1.84 Million - $2.15 Million
-16,598 Reduced 89.42%
1,963 $217 Million
Q2 2019

Jan 08, 2024
BUY
$110.79 - $129.32 $108,131 - $126,216
976 Added 56.74%
2,696 $218 Million
Q1 2019

Jan 08, 2024
BUY
$111.31 - $131.02 $191,453 - $225,354
1,720 New
1,720 $223 Million
Q4 2016

Jan 08, 2024
SELL
N/A
-3,753 Closed
0 $0
Q3 2016

Jan 08, 2024
SELL
N/A
-218 Reduced 5.49%
3,753 $301 Million
Q2 2016

Jan 08, 2024
SELL
N/A
-5 Reduced 0.13%
3,971 $313 Million
Q1 2016

Jan 08, 2024
SELL
N/A
-14,585
3,976 $286 Million

Others Institutions Holding LLY

# of Institutions
3,887
Shares Held
763M
Call Options Held
6.34M
Put Options Held
7.97M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email